Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study
Authors:
- Nicolai LohseNLNicolai Lohse
- Ann-Brit Eg HansenAHAnn-Brit Eg Hansen
- Søren Jensen-FangelSJSøren Jensen-Fangel
- Gitte KronborgGKGitte Kronborg
- Birgit KvinesdalBKBirgit Kvinesdal
- Court PedersenCPCourt Pedersen
- Carsten S. LarsenCLCarsten S. Larsen
- Axel MøllerAMAxel Møller
- Lars WillumsenLWLars Willumsen
- Niels ObelNONiels Obel
- 1 May 2005
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 37 (5) , 338-343
Abstract
We used a population-based cohort study design to describe the demographic characteristics of the HIV-infected population in Denmark and their variation over time. HIV treatment in Denmark is restricted to 9 centres, and all 3941 HIV-1 infected patients more than 15 y old seen at these centres in 1995-2003 were included. We found an estimated HIV prevalence of 70 per 100,000, and a mean annual incidence rate of 5.1 per 100,000 persons. The number of newly infected individuals was stable with a median of 231 per y (period 1995-2002), whereas the number of deaths decreased from 166 in 1995 to 50 in 2000 (p=0.000) and remained stable thereafter. Of the enrolled patients, 75% were males, 80% were Caucasian, 13% were black African, and the primary risk behaviour was male-to-male sexual contact (44%), heterosexual contact (36%), and injection drug use (11%). During the y 1995-2003 we found an increase in age at diagnosis (p=0.000), and no major changes in gender, race, mode of infection, or baseline CD4+ cell count and viral load, neither overall not within subgroups of patients. In this period 14.5% had AIDS at the time of HIV diagnosis. Our data do not confirm concerns about unmonitored evolution in the HIV epidemic in Denmark.Keywords
This publication has 8 references indexed in Scilit:
- The AIDS Epidemic in 2004New England Journal of Medicine, 2004
- Predictors of Immunological Failure after Initial Response to Highly Active Antiretroviral Therapy in HIV‐1–Infected Adults: A EuroSIDA StudyThe Journal of Infectious Diseases, 2004
- When are observational studies as credible as randomised trials?The Lancet, 2004
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysisThe Lancet, 2000
- Regional survival differences across Europe In HIV-positive people: the EuroSIDA studyAIDS, 1999
- Research Potentials and Pitfalls in the Use of an HIV Clinical Database: Chelsea and Westminster HospitalJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998